期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 46, 期 9, 页码 3039-3041出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.46.9.3039-3041.2002
关键词
-
资金
- NCRR NIH HHS [M01 RR001346, M01-RR-01346] Funding Source: Medline
- NIDCR NIH HHS [R01 DE011381, 5 R01 DE11381] Funding Source: Medline
The interaction between caspofungin acetate and voriconazole was studied in vitro by using 48 clinical Aspergillus spp. isolates obtained from patients with invasive aspergillosis. MICs were determined by the NCCLS broth microdilution method. Synergy, defined as a fractional inhibitory concentration (FIC) index of < 1, was detected in 87.5% of the interactions; an additive effect, defined as an FIC index of 1.0, was observed in 4.2% of the interactions; and a subadditive effect, defined as an FIC index of 1.0 to 2.0, was found in 8.3% of the interactions. No antagonism was observed. Animal models are required to validate the in vivo significance of these in vitro data presented for the combination of caspofungin and voriconazole.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据